Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11567218rdf:typepubmed:Citationlld:pubmed
pubmed-article:11567218lifeskim:mentionsumls-concept:C0019158lld:lifeskim
pubmed-article:11567218lifeskim:mentionsumls-concept:C0524910lld:lifeskim
pubmed-article:11567218lifeskim:mentionsumls-concept:C0262926lld:lifeskim
pubmed-article:11567218lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:11567218lifeskim:mentionsumls-concept:C0332119lld:lifeskim
pubmed-article:11567218lifeskim:mentionsumls-concept:C0175860lld:lifeskim
pubmed-article:11567218lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:11567218lifeskim:mentionsumls-concept:C0918012lld:lifeskim
pubmed-article:11567218lifeskim:mentionsumls-concept:C1554080lld:lifeskim
pubmed-article:11567218lifeskim:mentionsumls-concept:C1706198lld:lifeskim
pubmed-article:11567218pubmed:issue9lld:pubmed
pubmed-article:11567218pubmed:dateCreated2001-9-21lld:pubmed
pubmed-article:11567218pubmed:abstractTextTo analyze the spontaneous pathologic progression of chronic hepatitis C, we analyzed the histopathologic semiquantitative scores (Metavir and Knodell) of sequential liver biopsies performed in untreated hepatitis C virus (HCV)-infected patients. Subjects included 35 men and 41 women, with a mean age of 41 +/- 12 years, a duration of HCV infection of 11 +/- 5 years, and an interval between liver biopsies of 3.7 +/- 2.5 years. Results obtained using the Knodell score and the Metavir score were similar. At the first biopsy, 78.9% of patients had a low activity score (A0-A1) and 82.9% had a low fibrosis score (F0-F2). At the second biopsy, the activity decreased in 9.2%, was unchanged in 72.4%, and increased in 18.5%. An increase in activity was more frequently observed in patients infected with genotype 1 (28.9%) than with others (7.7%; P =.04); the yearly progression of activity was significantly higher in patients with a low rather than high initial activity score (0.11 v -0.02; P <.01). An increase in fibrosis was noted in 13.3% of those with a low and 43.8% of those with a high initial activity score (P <.01), with a highest rate of yearly fibrosis progression (0.12 U). In multivariate analysis, only a high activity score was significantly associated with an increased risk of fibrosis progression (relative risk, 25.5; 95% confidence interval, 2.7 to 238; P =.004). Spontaneous chronic hepatitis C evolution is worsening in only 20% of patients. Fibrosis progression is significantly associated with the necroinflammatory activity suggesting that this factor should be regarded as a major clue for deciding therapy.lld:pubmed
pubmed-article:11567218pubmed:languageenglld:pubmed
pubmed-article:11567218pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11567218pubmed:citationSubsetIMlld:pubmed
pubmed-article:11567218pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11567218pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11567218pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11567218pubmed:statusMEDLINElld:pubmed
pubmed-article:11567218pubmed:monthSeplld:pubmed
pubmed-article:11567218pubmed:issn0046-8177lld:pubmed
pubmed-article:11567218pubmed:authorpubmed-author:BrechotCClld:pubmed
pubmed-article:11567218pubmed:authorpubmed-author:FontaineHHlld:pubmed
pubmed-article:11567218pubmed:authorpubmed-author:CarnotFFlld:pubmed
pubmed-article:11567218pubmed:authorpubmed-author:WuP PPPlld:pubmed
pubmed-article:11567218pubmed:authorpubmed-author:NalpasBBlld:pubmed
pubmed-article:11567218pubmed:authorpubmed-author:ZylberbergHHlld:pubmed
pubmed-article:11567218pubmed:authorpubmed-author:PouletBBlld:pubmed
pubmed-article:11567218pubmed:copyrightInfoCopyright 2001 by W.B. Saunders Companylld:pubmed
pubmed-article:11567218pubmed:issnTypePrintlld:pubmed
pubmed-article:11567218pubmed:volume32lld:pubmed
pubmed-article:11567218pubmed:ownerNLMlld:pubmed
pubmed-article:11567218pubmed:authorsCompleteYlld:pubmed
pubmed-article:11567218pubmed:pagination904-9lld:pubmed
pubmed-article:11567218pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11567218pubmed:meshHeadingpubmed-meshheading:11567218...lld:pubmed
pubmed-article:11567218pubmed:meshHeadingpubmed-meshheading:11567218...lld:pubmed
pubmed-article:11567218pubmed:meshHeadingpubmed-meshheading:11567218...lld:pubmed
pubmed-article:11567218pubmed:meshHeadingpubmed-meshheading:11567218...lld:pubmed
pubmed-article:11567218pubmed:meshHeadingpubmed-meshheading:11567218...lld:pubmed
pubmed-article:11567218pubmed:meshHeadingpubmed-meshheading:11567218...lld:pubmed
pubmed-article:11567218pubmed:meshHeadingpubmed-meshheading:11567218...lld:pubmed
pubmed-article:11567218pubmed:meshHeadingpubmed-meshheading:11567218...lld:pubmed
pubmed-article:11567218pubmed:meshHeadingpubmed-meshheading:11567218...lld:pubmed
pubmed-article:11567218pubmed:meshHeadingpubmed-meshheading:11567218...lld:pubmed
pubmed-article:11567218pubmed:meshHeadingpubmed-meshheading:11567218...lld:pubmed
pubmed-article:11567218pubmed:meshHeadingpubmed-meshheading:11567218...lld:pubmed
pubmed-article:11567218pubmed:meshHeadingpubmed-meshheading:11567218...lld:pubmed
pubmed-article:11567218pubmed:year2001lld:pubmed
pubmed-article:11567218pubmed:articleTitleHepatitis activity index is a key factor in determining the natural history of chronic hepatitis C.lld:pubmed
pubmed-article:11567218pubmed:affiliationUnité d'Hépatologie and INSERM U370, Hôpital Necker, Paris, France.lld:pubmed
pubmed-article:11567218pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11567218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11567218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11567218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11567218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11567218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11567218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11567218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11567218lld:pubmed